The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases
Cells · 26.10.2023 · 12 (21) · 2528
DOI: 10.3390/cells12212528 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 26.10.2023. Verfasst von Isaac M Emon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Queen's University, Kingston, ON K7L 3N6, Canada. Hauptthemen laut MEDLINE: Pulmonary Arterial Hypertension, Cardiovascular Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research (CIHR), William James Henderson Foundation, Canadian Foundation for Innovation.
Abstract (Originalsprache)
DNA methylation is an epigenetic mechanism that regulates gene expression without altering gene sequences in health and disease. DNA methyltransferases (DNMTs) are enzymes responsible for DNA methylation, and their dysregulation is both a pathogenic mechanism of disease and a therapeutic target. DNMTs change gene expression by methylating CpG islands within exonic and intergenic DNA regions, which typically reduces gene transcription. Initially, mutations in the DNMT genes and pathologic DNMT protein expression were found to cause hematologic diseases, like myeloproliferative disease and acute myeloid leukemia, but recently they have been shown to promote cardiovascular diseases, including coronary artery disease and pulmonary hypertension. We reviewed the regulation and functions of DNMTs, with an emphasis on somatic mutations in DNMT3A, a common cause of clonal hematopoiesis of indeterminant potential (CHIP) that may also be involved in the development of pulmonary arterial hypertension (PAH). Accumulation of somatic mutations in DNMT3A and other CHIP genes in hematopoietic cells and cardiovascular tissues creates an inflammatory environment that promotes cardiopulmonary diseases, even in the absence of hematologic disease. This review summarized the current understanding of the roles of DNMTs in maintenance and de novo methylation that contribute to the pathogenesis of cardiovascular diseases, including PAH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Queen's University, Kingston, ON K7L 3N6, Canada.
- Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON K7L 3N6, Canada.
ORCID-Profile: Michael J Rauh, Stephen L Archer
Förderung
- Canadian Institutes of Health Research (CIHR)
- William James Henderson Foundation
- Canadian Foundation for Innovation
- Translational Institute of Medicine (TIME)
- QCPU
Zitieren
APA
Emon, I. M., Al-Qazazi, R., Rauh, M. J., & Archer, S. L. (2023). The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases. Cells, 12(21), 2528. https://doi.org/10.3390/cells12212528
Vancouver
Emon IM, Al-Qazazi R, Rauh MJ, Archer SL. The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases. Cells. 2023;12(21):2528. doi:10.3390/cells12212528
BibTeX
@article{Emon2023,
author = {Emon, Isaac M and Al-Qazazi, Ruaa and Rauh, Michael J and Archer, Stephen L},
title = {The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases},
journal = {Cells},
year = {2023},
volume = {12},
number = {21},
pages = {2528},
doi = {10.3390/cells12212528}
}
EUVIMED